Apex Healthcare Berhad (KLSE:AHEALTH)

Market Cap	n/a
Revenue (ttm)	970.14M +0.6%
Net Income	65.46M -21.3%
EPS	0.09 -21.3%
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	0.09 (3.45%)
Ex-Dividend Date	Sep 4, 2025

Volume	262,400
Average Volume	868,380
Open	2.610
Previous Close	2.610
Day's Range	2.610 - 2.610
52-Week Range	1.900 - 2.650
Beta	0.08
RSI	54.34
Earnings Date	Feb 25, 2026

About Apex Healthcare Berhad

Apex Healthcare Berhad, an investment holding company, engages in the development, manufacture, marketing, distribution, and wholesale of pharmaceutical and healthcare products in Malaysia, Singapore, and internationally. It operates in three segments: Manufacturing, Distribution, and Corporate. The company offers a range of products, including cough mixture and antihistamine, anti-infective, anti-diabetic, anti-hypertensive, neuromuscular agent, analgesic, dermatological, and ophthalmological products in the form of tablets, capsules, oral liq...

• Industry: Pharmaceutical Preparations
• Founded: 1962
• Employees: 917
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: AHEALTH

Financial Performance

In 2024, Apex Healthcare Berhad's revenue was 961.78 million, an increase of 2.74% compared to the previous year's 936.17 million. Earnings were 76.54 million, a decrease of -80.77%.